Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Amrize's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Amrize's regulatory disclosures and financial reporting.
Thomas Schmidheiny and affiliated entities disclosed a significant 6.671% ownership stake in Amrize through a Schedule 13D filing. The position was acquired following Amrize's spin-off from Holcim on June 23, 2025.
Key ownership details:
- Total beneficial ownership of 37,818,703 ordinary shares
- Schweizerische Cement-Industrie-Aktiengesellschaft (SCIA) holds 37,111,376 shares (6.547%)
- Cimcap AG holds 678,450 shares (0.120%)
- Shares received as dividend-in-kind through Holcim's distribution
The spin-off separated Amrize's North American operations (US, Canada, Jamaica) from Holcim's global business. The reporting persons, all Swiss entities, have not disclosed specific plans regarding their investment but maintain the right to acquire additional shares or sell their position based on ongoing evaluation of business conditions and opportunities.